{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Client Logo
  • Sign In
  • Browse By Specialty
  • Live Courses
  • RSS
  • On-Demand
  • Journal Based
  • Disclosures
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

If you are a UCI employee, please log in with your UCInetID credentials.

If you are new to UCI CME and/or have not registered for a course yet, please create an account.

 

Note for non-UCI employees: After 3 incorrect password attempts, your account will be locked. To unlock it, email [email protected].

UCInetID Login (UCI Employees)
Sign-In or Create Account (Non-UCI Employees Only)
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • APRN
  • BSN
  • BSRT
  • CCT
  • CNM
  • CRNA
  • CRNP
  • CTR
  • CVT
  • DDS
  • DMD
  • DO
  • DO, MBA
  • DPM
  • DPT
  • EMT
  • EMT-P
  • JD
  • LCSW
  • LMFT
  • LNM
  • LPCC
  • LPN
  • MA
  • MBA
  • MBBS
  • MD
  • MD, DPM
  • MD, JD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MHA
  • MPH
  • MS
  • MSN
  • MSPH
  • MSW
  • None
  • NP
  • OD
  • OT
  • Other
  • OTR
  • PA-C
  • PharmD
  • PhD
  • PsyD
  • PT
  • RCES
  • RD
  • RN
  • RN, BSN
  • RPh
  • RT
  • RTT
  • SLP
Degree is required
Please enter your degree:
You must enter a degree

Profession is required

User Agreement

CloudCME® know you care about the privacy and confidentiality of your information. We take protecting your privacy very seriously. The CME Program is a program administered by CloudCME®.

Please read the CME Program Notice of Privacy Practices about how we treat your information collected as part of the CME Program. By using the CME website and participating in the CME Program in any manner, you acknowledge that you accept the practices and policies outlined in this CME Program Notice of Privacy Practices.



You must agree to the terms and conditions before registering.




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
  • Anesthesiology & Perioperative Care
  • Dermatology
  • Emergency Medicine
  • Family Medicine
  • Medicine
  • Neurological Surgery
  • Neurology
  • Obstetrics & Gynecology
  • Ophthalmology
  • Orthopaedic Surgery
  • Otolaryngology - Head & Neck Surgery
  • Pathology & Laboratory Medicine
  • Pediatrics
  • Physical Medicine & Rehabilitation
  • Plastic Surgery
  • Psychiatry & Human Behavior
  • Radiation Oncology
  • Radiological Sciences
  • Surgery
  • Urology
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

UC Irvine Gavin Herbert Eye Institute 19th Annual Colloquium


UC Irvine Gavin Herbert Eye Institute 19th Annual Colloquium Banner

  • Overview
  • Register
  • Faculty Disclosures
  • Schedule
  • Exhibitors
  • Support
Add to Calendar UC Irvine Gavin Herbert Eye Institute 19th Annual Colloquium 10/3/2025 7:00:00 AM 10/4/2025 1:30:00 PM America/Los_Angeles For More Details: https://uci.cloud-cme.com/2025-ghei-colloquium Description: The Gavin Herbert Eye Institute will organize this educational conference, which will be held on October 3-4, 2025. Goals: 1) to bring together vision clinicians and researchers from UC Irvine and the rest of the world so we can expand our knowledge and collaborate; 2) to promote education and interactions with local, regional, national and global Ophthalmology health care providers; and 3) to expand our interactio... Arnold and Mabel Beckman Center false MM/DD/YYYY


Date & Location
Friday, October 3, 2025, 7:00 AM - Saturday, October 4, 2025, 1:30 PM, Arnold and Mabel Beckman Center, Irvine, CA

Target Audience
Specialties - Ophthalmology
Professions - Medical Student, Physician, Resident Physician

Credits
AMA PRA Category 1 Credits™ (12.00 hours), Non-Physician Attendance (12.00 hours)

Overview

The Gavin Herbert Eye Institute will organize this educational conference, which will be held on October 3-4, 2025. Goals: 1) to bring together vision clinicians and researchers from UC Irvine and the rest of the world so we can expand our knowledge and collaborate; 2) to promote education and interactions with local, regional, national and global Ophthalmology health care providers; and 3) to expand our interactions with the ophthalmic companies in the area. Speakers include UC Irvine Gavin Herbert Eye Institute ophthalmologists and researchers, and guest speakers who are specialists in their fields. Opportunity for ophthalmic companies to exhibit. The goal of this year’s conference is to create synergy by bringing clinicians and researchers together to establish collaborations. Ophthalmologists interested in the comprehensive, clinical applications and translational research that address eye diseases are the main target audience.

Registration Fees

  • $175 Early Bird Registration

  • $225 Beginning September 3

Click the register tab above to see further details for

  • GHEI Faculty, Staff, Residents, Fellows & Medical Students Registration

  • Exhibitor Registration

  • Sponsorship Registration


Objectives
At the conclusion of this activity, learners will be able to:

  1. Understand refractive surgery market trends
  2. Apply guides for step-by-step office-based corneal procedures
  3. Explain the prevention and management of pseudophakic macular edema
  4. Implement pharmacological, optical and lifestyle interventions for myopia control
  5. Evaluate systemic medication toxicity with an emphasis on neuro-ophthalmic manifestations
  6. Recall angle closure considerations during cataract surgery
  7. Identify ocular inflammatory masqueraders
  8. Consider innovations in eyelid reconstruction after trauma or tumor resection
  9. Apply pearls for success in private practice as shared in the UCI Alumni Showcase

Accreditation
University of California, Irvine School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Additional Information

ADA Statement: In compliance with the Americans with Disabilities Act, we will make every reasonable effort to accommodate your request.  For any special requests, please contact the activity administrator before the meeting date.


Event Contact: Dana Collison at [email protected].



The University of California, Irvine School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.



Mitigation of Relevant Financial Relationships


University of California, Irvine School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Dana Collinson, BA
Marketing & Special Events Director
UCI Gavin Herbert Eye Institute
Activity Coordinator
Nothing to disclose
Luis Delgado, MHA
UCI Gavin Herbert Eye Institute
Activity Coordinator
Nothing to disclose
Melody Yang
Gavin Herbert Eye Institute
Activity Coordinator
Nothing to disclose
Faculty Photos
Lilangi Ediriwickrema, MD
Associate Professor of Ophthalmology
UCI School of Medicine
Co-Director, Faculty
Nothing to disclose
Faculty Photos
Matthew Wade, MD
Associate Professor of Ophthalmology
UC Irvine School of Medicine
Co-Director, Faculty
Consulting Fee-Johnson & Johnson|Consulting Fee-Glaukos
Daniel Azzam, MD
Faculty
Nothing to disclose
Faculty Photos
Andrew Browne, MD, PhD
Faculty
Grant or research support-Alcon (Any division)|Grant or research support-Carl Zeiss Meditec
Winston Chamberlain, MD, PhD, Affiliate Professor of Ophthalmology
Affiliate Professor of Ophthalmology
VisionGift and Northwest Permanente
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Emmecell|Advisor-Neumora|Paid consultant-GlaxoSmithKline|Advisor-Viatris|Paid consultant-Abbvie|Grant or research support-ReGenTree|Grant or research support-Emmecell
Faculty Photos
Robert W. Crow, MD
Professor of Ophthalmology
UCI School of Medicine
Faculty
Nothing to disclose
Faculty Photos
Maria Del Valle Estopinal, MD
Faculty
Nothing to disclose
Marjan Farid, MD
Gavin Herbert Eye Institute
Faculty
Consulting Fee-AbbVie (Any division)|Consulting Fee-Johnson & Johnson|Consulting Fee-Bausch & Lomb (Any division)|Consulting Fee-Alcon (Any division)
Faculty Photos
Austin Fox, MD
Assistant Professor of Ophthalmology
UCI School of Medicine
Faculty
Paid consultant-New World Medical (Relationship has ended)|Paid consultant-Alcon (Any division) (Relationship has ended)
Faculty Photos
Sumit (Sam) Garg, MD
Professor and Vice Chair of Ophthalmology
UCI School of Medicine
Faculty
Consulting Fee-Johnson & Johnson|Consulting Fee-Aldeyra|Consulting Fee-AbbVie (Any division)|Consulting Fee-BVI|Consulting Fee-CorneaGen|Honoraria-Dompe|Honoraria-Expert Opinion|Consulting Fee-Emmecell|Advisor-ForSight Robotics|Consulting Fee-Glaukos|Consulting Fee-Rayner|Consulting Fee-Sight Sciences|Advisor-SpyGlass|Consulting Fee-Tarsus|Consulting Fee-Versea|Consulting Fee-Visus|Consulting Fee-Zeiss|Consulting Fee-Azura|Consulting Fee-Aliph|Consulting Fee-Signal 12
Kimberly K Gokoffski, MD, PhD
Associate Professor
USC
Faculty
Nothing to disclose
Faculty Photos
Charlotte Gore, MD
Associate Professor of Ophthalmology
UC Irvine School of Medicine
Faculty
Nothing to disclose
Faculty Photos
Seanna Grob, MD
Associate Professor of Ophthalmology
UCI School of Medicine
Faculty
Nothing to disclose
Faculty Photos
Andrew Harrison, MD
Professor
University of Minnesota
Faculty
Speakers Bureau-Amgen, Inc.|Independent Contractor (included contracted research)-Viridian
Sanjay Kedhar, MD
UCI
Faculty
Speakers Bureau-ANI Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-ANI Pharmaceuticals|Independent Contractor (included contracted research)-Priovant Therapeutics|Independent Contractor (included contracted research)-Visus Therapeutics (Relationship has ended)|Consulting Fee-Glaukos|Honoraria-ALCON (Relationship has ended)
Brian Kim, MD
Faculty
Darren Knight, MD
Faculty
Nothing to disclose
Baruch Kuppermann, MD, PhD
Gavin Herbert Eye Institute, University of California, Irvine
Faculty
Grant or research support-AbbVie (Any division)|Grant or research support-Adverum|Grant or research support-Apellis|Grant or research support-Clearside|Grant or research support-EyePoint|Grant or research support-4DMT|Grant or research support-Genentech (Any division)|Grant or research support-Ionis Pharmaceuticals|Grant or research support-jCyte|Grant or research support-Ray Therapeutics|Grant or research support-Regeneron Pharmaceuticals, Inc.|Grant or research support-RegenXBio|Paid consultant-AbbVie (Any division)|Paid consultant-Adverum|Paid consultant-Alkeus|Paid consultant-Allegro Ophthalmics|Paid consultant-Amgen|Paid consultant-Apellis|Paid consultant-Astellas|Paid consultant-Aviceda Therapeutics|Paid consultant-Boehringer Ingelheim Pharmaceuticals, Inc.|Paid consultant-Clearside|Paid consultant-Coherus|Paid consultant-EyeBio|Paid consultant-Eyedaptic|Paid consultant-EyePoint|Paid consultant-4DMT|Paid consultant-Genentech (Any division)|Paid consultant-Glaukos|Paid consultant-InflammX|Paid consultant-jCyte|Paid consultant-Mobius|Paid consultant-Molecular Partners|Paid consultant-Neurotech|Paid consultant-Novartis Corporation Pharmaceuticals|Paid consultant-Ocular Therapeutix|Paid consultant-Oculis|Paid consultant-OphtiMedRx|Paid consultant-Opthea|Paid consultant-Outlook Therapeutics|Paid consultant-Priviterra|Paid consultant-Regeneron Pharmaceuticals, Inc.|Paid consultant-ReVana Therapeutics|Paid consultant-Ripple Therapeutics|Paid consultant-Roche (Any division)|Paid consultant-Santen|Paid consultant-Stealth Therapeutics|Paid consultant-Theravance Biopharma|Paid consultant-Visgenx
Olivia L Lee, MD
Clinical Professor
UCI School of Medicine
Faculty
Consulting Fee-Cloudbreak Therapeutics|Consulting Fee-Harrow|Speakers Bureau-Dompe|Other: Lecture Fees-CorneaGen|Other: Lecture Fees-Recordati Rare Diseases (Relationship has ended)
Faculty Photos
Ken Y. Lin, MD, PhD
Associate Professor of Ophthalmology
UCI School of Medicine
Faculty
Consulting Fee-Alcon (Any division)|Consulting Fee-Microsurgical Tehcnology
Faculty Photos
Stephanie Lu, MD
Professor of Ophthalmology
UCI School of Medicine
Faculty
Nothing to disclose
Amir Marvasti, MD
Coastal Vision
Faculty
Paid consultant-Glaukos|Paid consultant-BVI
Faculty Photos
Mitul Mehta, MD
Faculty
Consulting Fee-AbbVie (Any division)|Grant or research support-Syneos Health|Grant or research support-Genentech (Any division)|Grant or research support-RegenxBio (Relationship has ended)|Consulting Fee-Adverum (Relationship has ended)|Consulting Fee-Sandoz|Consulting Fee-Astellas (Any division)|Consulting Fee-ANI|Consulting Fee-Apellis|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Eyedaptic |Grant or research support-jCyte|Consulting Fee-Zeiss
Faculty Photos
Kapil Mishra, MD
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-AbbVie (Any division) (Relationship has ended)|Consulting Fee-Zeiss|Consulting Fee-Bausch & Lomb (Any division) (Relationship has ended)
Sameh Mosaed, MD
Gavin Herbert Eye Institute
Faculty
Consulting Fee-Skye Biosciences (Relationship has ended)|Honoraria-Thea Pharmaceuticals|Grant or research support-Sight Sciences|Advisor-Alcon (Any division)
Philip Ngai, MD
San Gabriel Valley Eye Institute
Faculty
Nothing to disclose
Theodore Pasquali, MD
SoCal Eye
Faculty
Alpa Patel, MD
Associate Professor
GHEI
Faculty
Nothing to disclose
Faculty Photos
Vivek Patel, MD
Professor of Ophthalmology
UCI School of Medicine
Faculty
Advisor-Novo Nordisk (Any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Catalyst
Stephen Prepas, MD
Attending Physician
GHEI
Faculty
Nothing to disclose
Faculty Photos
Mohammad Riazi, MD
Faculty
Nothing to disclose
Keith Rundle, MD, Fellow American Academy of Ophthalmology
Associate Professor of Ophthalmolgy
UCI
Faculty
Nothing to disclose
Faculty Photos
Andrew K. Smith, MD
Assistant Professor of Ophthalmology
UCI School of Medicine
Faculty
Consulting Fee-Alcon (Any division)
Jennifer Soun, MD
Faculty
Nothing to disclose
Faculty Photos
Samuel J Spiegel, MD
Assistant Professor of Ophthalmology
UC Irvine School of Medicine
Faculty
Nothing to disclose
Faculty Photos
Jeremiah Tao, MD
Professor of Ophthalmology
UCI School of Medicine
Faculty
Nothing to disclose
Kimberly Walker, OD
UCi
Faculty
Nothing to disclose
Kate Xie, MD
Faculty
Nothing to disclose

Friday, October 3, 2025
Registration | Breakfast
7:00AM - 8:00AM

Welcome
8:00AM - 8:15AM

Session #1 - Retina
8:15AM - 8:20AM
Baruch Kuppermann, MD, PhD (Panelist)
Stephanie Lu, MD (Moderator)
Stephanie Lu, MD (Speaker)
Andrew Browne, MD, PhD (Panelist)
Andrew Browne, MD, PhD (Speaker)
Mitul Mehta, MD (Panelist)
Kapil Mishra, MD (Panelist)
Mohammad Riazi, MD (Panelist)

Current treatment guidelines for wet and dry age-related macular degeneration
8:16AM - 8:26AM
Baruch Kuppermann, MD, PhD

Pseudophakic macular edema - what is it, why is it, and prevention managemetn
8:26AM - 8:36AM
Andrew Browne, MD, PhD (Speaker)

Managing DME in patients and undergoing cataract surgery
8:36AM - 8:46AM
Stephanie Lu, MD

Managing tractional detachment due to diabetic retinopathy
8:44AM - 8:56AM
Mitul Mehta, MD

Managing recurrent retinal detachment due to proliferative vitreoretinopathy
8:56AM - 9:06AM
Mohammad Riazi, MD

From soup to nuts: Primary vitreoretinal lymphoma
9:06AM - 9:15AM
Kapil Mishra, MD

Panel: Pearls for success in private practice
9:15AM - 10:00AM
Matthew Wade, MD (Moderator)
Matthew Wade, MD (Speaker)
Keith Rundle, MD, Fellow American Academy of Ophthalmology (Panelist)
Darren Knight, MD (Panelist)
Philip Ngai, MD (Panelist)
Brian Kim, MD (Panelist)
Kate Xie, MD (Panelist)

Morning Break with Exhibitors
10:00AM - 10:30AM

Session #2 - Pediatric Update
10:30AM - 10:35AM
Charlotte Gore, MD (Moderator)

Myopia treatment: pharmacological, optical and lifestyle interventions
10:31AM - 10:40AM
Charlotte Gore, MD (Speaker)

Current treatments for juvenile idiopathic arthretis interventions
10:41AM - 10:51AM
Stephen Prepas, MD (Speaker)

Amblyopia management: binocular vs. monocular therapy
10:51AM - 11:00AM
Kimberly Walker, OD (Speaker)

Cataract | Refractive Panel
11:00AM - 12:00PM
Matthew Wade, MD (Panelist)
Sumit (Sam) Garg, MD (Panelist)
Marjan Farid, MD (Moderator)
Marjan Farid, MD (Speaker)
Sanjay Kedhar, MD (Panelist)
Winston Chamberlain, MD, PhD, Affiliate Professor of Ophthalmology (Panelist)

Lunch | Networking | Exhibitors: Lunch Roundtables: #1 - Tips on starting your own practice; #2 - Tips on joining a practice and contract negotiations; #3 - Social Media. Discussions hosted by Gavin Herbert Eye Institute Alumni
12:00PM - 1:30PM

Roger Steinert Memorial Lecture - Introduction
1:30PM - 1:35PM
Marjan Farid, MD (Moderator)

Roger Steinert Memorial Lecture: Ocular suface manifestations of biologics
1:35PM - 2:15PM
Winston Chamberlain, MD, PhD, Affiliate Professor of Ophthalmology (Speaker)

Session #3: Cornea | Uveitis
2:15PM - 2:20PM
Sanjay Kedhar, MD (Moderator)

Aniridia: limbal stem cell transplant and artificial iris implant
2:16PM - 2:25PM
Matthew Wade, MD (Speaker)
Marjan Farid, MD (Speaker)

How to differentiate between uveitis and neoplastic disease masquerades
2:25PM - 2:35PM
Sanjay Kedhar, MD (Speaker)

Pearls from the DETECT study
2:35PM - 2:50PM
Winston Chamberlain, MD, PhD, Affiliate Professor of Ophthalmology (Speaker)

Cornea: Office based corneal procedures - step-by-step guide
2:50PM - 2:51PM
Marjan Farid, MD (Moderator)
Marjan Farid, MD (Speaker)

Is LASIK safe?
2:50PM - 3:00PM
Theodore Pasquali, MD (Speaker)

Salzmann nodules
3:00PM - 3:04PM
Sumit (Sam) Garg, MD (Speaker)

Recurrent corneal erosion
3:04PM - 3:08PM
Marjan Farid, MD (Speaker)

Superior limbic keratitis
3:08PM - 3:12PM
Matthew Wade, MD (Speaker)

Corneal perforation
3:12PM - 3:16PM
Sanjay Kedhar, MD (Speaker)

Corneal tattoo
3:16PM - 3:20PM
Winston Chamberlain, MD, PhD, Affiliate Professor of Ophthalmology (Speaker)

Afternoon Break with Exhibitors
3:20PM - 3:50PM

Session #4: Emerging Technologies
3:50PM - 4:50PM
Sumit (Sam) Garg, MD
Charlotte Gore, MD (Moderator)

Refractive surgery
3:51PM - 4:00PM
Marjan Farid, MD (Speaker)

Glaucoma
4:00PM - 4:06PM
Austin Fox, MD (Speaker)

Neuroophthalmology
4:06PM - 4:13PM
Kimberly K Gokoffski, MD, PhD

Pediatrics
4:13PM - 4:19PM
Charlotte Gore, MD (Speaker)

Retina
4:19PM - 4:26PM
Baruch Kuppermann, MD, PhD (Speaker)

Uveitis
4:26PM - 4:32PM
Sanjay Kedhar, MD (Speaker)

Oculoplastics
4:32PM - 4:38PM
Andrew Harrison, MD (Speaker)

Cataract
4:38PM - 4:44PM
Alpa Patel, MD (Speaker)

Cornea
4:44PM - 4:50PM
Winston Chamberlain, MD, PhD, Affiliate Professor of Ophthalmology (Speaker)

Closing Remarks
4:45PM - 4:50PM
Lilangi Ediriwickrema, MD (Speaker)

Reception
4:50PM - 6:00PM

Saturday, October 4, 2025
Registration | Breakfast
7:00AM - 8:00AM

Session #5: Oculoplastics
8:00AM - 8:01AM
Seanna Grob, MD (Moderator)

Management of eyelid malpositions in pediatric patients
8:01AM - 8:15AM
Jeremiah Tao, MD (Speaker)

Orbital tumors: advances in diagnostic imaging and surgical planning
8:15AM - 8:30AM
Lilangi Ediriwickrema, MD (Speaker)

Advances in hemostasis in oculoplastic surgery
8:30AM - 8:45AM
Seanna Grob, MD (Speaker)

Gavin Herbert Lecture - Introduction
8:45AM - 8:50AM
Jeremiah Tao, MD (Moderator)

Gavin Herbert Lecture: Facial beauty and blepharoplasty
8:50AM - 9:30AM
Andrew Harrison, MD (Speaker)

Morning Break with Exhibitors
9:30AM - 10:00AM

Session #6: Glaucoma
10:00AM - 10:41AM
Andrew K. Smith, MD (Moderator)

Non-pharmacologic interventions to augment prevention and treatment of glaucoma
10:01AM - 10:10AM
Sameh Mosaed, MD (Speaker)

Impact of the MIGS revolution on advanced glaucoma
10:10AM - 10:20AM
Austin Fox, MD (Speaker)

Cataract surgery in the patient with angle closure
10:20AM - 10:30AM
Andrew K. Smith, MD (Speaker)

Artificial intelligence applications in glaucoma
10:30AM - 10:40AM
Ken Y. Lin, MD, PhD (Speaker)

SESSION #7: Neuro-ophthalmology
10:40AM - 10:41AM
Samuel J Spiegel, MD (Moderator)

Neuro-ophthalmic manifestations of systemic medication toxicity
10:41AM - 10:50AM
Vivek Patel, MD (Speaker)

Neuro-ophthalmic manifestations of systemic medication toxicity
10:41AM - 10:50AM
Vivek Patel, MD (Speaker)
Robert W. Crow, MD (Speaker)

Artificial intelligence in diagnosing and monitoring papilledema
10:50AM - 11:00AM
Samuel J Spiegel, MD (Speaker)

Updates on the management of demyelinating disease
11:00AM - 11:10AM
Kimberly K Gokoffski, MD, PhD (Speaker)

Hot orbit -- approach to acute orbital disease
11:10AM - 11:20AM
Andrew Harrison, MD (Speaker)

SESSION #8: Repair of cataract surgeryl complications
12:00PM - 12:01PM
Matthew Wade, MD (Moderator)

Yamane
12:01PM - 12:08PM
Sumit (Sam) Garg, MD (Speaker)

Two point prolene fixation
12:08PM - 12:15PM
Matthew Wade, MD (Speaker)

Single point prolene fixation
12:15PM - 12:22PM
Marjan Farid, MD (Speaker)

Iris prolapse
12:22PM - 12:29PM
Winston Chamberlain, MD, PhD, Affiliate Professor of Ophthalmology (Speaker)

Closing Remarks | Adjourn
12:29PM - 12:34PM
Matthew Wade, MD (Moderator)
Baruch Kuppermann, MD, PhD (Moderator)

Refreshments | Networking
12:34PM - 1:30PM

CorneaGen’s mission is to provide the highest quality donor tissue, unparalleled customer service and superior products that transform how ophthalmologists treat and care for every person impacted by corneal disease. Through continuous innovations in tissue processing technology and surgical devices, advocacy for patient access and simplified payor reimbursement policies, CorneaGen is advancing the next generation of cornea care.

As the world’s leading eye bank, CorneaGen has multiple locations and local partnerships throughout the U.S. to deliver the life-changing gift of sight to tens of thousands of people each year.

 

Dompé is an Italian biopharmaceutical company with a 130 year legacy of medical innovation. Based in Milan with US headquarters in the San Francisco Bay Area, Dompé is committed to medical and scientific advancements that address unmet medical needs in the areas of ophthalmology, transplants, oncology, and diabetes. To learn more about Dompé, email [email protected]

 

Glaukos is committed to investing in the future of ophthalmology to transform standards of care and improve patient lives.

We’ve achieved many firsts in clinical studies and over the past several years, Glaukos has reinvested approximately 30% of all sales back into research and development activities – all to relentlessly advance our goal of creating and delivering transformative therapies for patients struggling with eye diseases and the skilled surgeons dedicated to their healing.

Innovation is at the core of everything we do. Our mission at Glaukos is to truly transform vision by pioneering novel, dropless platforms that can meaningfully advance the standard of care and improve outcomes for patients suffering from sight-threatening chronic eye diseases. Our mantra “We’ll Go First” embodies our commitment and determination to take chances and push the limits of science and technology to disrupt and improve the legacy treatment paradigms in glaucoma, corneal disorders, and retinal diseases.

 

Genentech 

Genentech, a member of the Roche Group, has more than 40 years of experience in the field of biotechnology. Genentech is researching and developing new treatments for people living with a range of eye diseases that cause significant visual impairment and blindness, including wet age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), geographic atrophy (GA), and other retinal diseases.

 

At Johnson & Johnson Vision, we have a bold ambition: to change the trajectory of eye health. Through our operating companies, we’ve developed solutions for every stage of life-to help people see better, connect better, and live better. We partner with eye care professionals to provide some of the world's leading products and technologies to address refractive error, cataracts, dry eye, and beyond. We are committed to using our reach and size for good and strive to put quality eye care within reach of everyone, everywhere. Click the logo for more information. 

We Are Alcon We help the world see, look and feel better. And after our first 70 years, we are just getting started. Discover our story. Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care.

 

Seventy-five years ago, Gavin S. Herbert, Sr, and his son, Gavin Herbert, Jr, created Allergan, an AbbVie company, with the goal of improving the lives of patients. Since that time, Allergan has remained dedicated to advancing eye care, launching 125+ products for prevalent eye conditions. We are committed to helping Eye Care Providers deliver superior patient care through R&D, philanthropy, outreach programs, and support of academic institutions. © 2025 AbbVie. All rights reserved. All trademarks are the property of their respective owners. AllerganEyeCare.com US-ABBV-230085 04/2 

 

ANI Pharmaceuticals is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products. We are focused on building a successful Purified Cortrophin® Gel franchise, strengthening our generics business and established brands, and leveraging our North American manufacturing capabilities. For more information, please visit www.anipharmaceuticals.com or www.cortrophin.com.

 

Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), Argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. Argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker, globally in the U.S., Japan, Israel, the EU, the UK, China and Canada. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises.

 

Astellas is a pharmaceutical company dedicated to improving the health of people around the world by identifying, developing, and delivering next generation treatments.

 

CorneaGen’s mission is to provide the highest quality donor tissue, unparalleled customer service and superior products that transform how ophthalmologists treat and care for every person impacted by corneal disease. Through continuous innovations in tissue processing technology and surgical devices, advocacy for patient access and simplified payor reimbursement policies, CorneaGen is advancing the next generation of cornea care.

As the world’s leading eye bank, CorneaGen has multiple locations and local partnerships throughout the U.S. to deliver the life-changing gift of sight to tens of thousands of people each year.

 

Dompé is an Italian biopharmaceutical company with a 130 year legacy of medical innovation. Based in Milan with US headquarters in the San Francisco Bay Area, Dompé is committed to medical and scientific advancements that address unmet medical needs in the areas of ophthalmology, transplants, oncology, and diabetes. To learn more about Dompé, email [email protected]

 

Genentech, a member of the Roche Group, has more than 40 years of experience in the field of biotechnology. Genentech is researching and developing new treatments for people living with a range of eye diseases that cause significant visual impairment and blindness, including wet age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), geographic atrophy (GA), and other retinal diseases. To learn more, visit https://www.ophthalmologyvision.com

 

Glaukos is committed to investing in the future of ophthalmology to transform standards of care and improve patient lives.

We’ve achieved many firsts in clinical studies and over the past several years, Glaukos has reinvested approximately 30% of all sales back into research and development activities – all to relentlessly advance our goal of creating and delivering transformative therapies for patients struggling with eye diseases and the skilled surgeons dedicated to their healing.

Innovation is at the core of everything we do. Our mission at Glaukos is to truly transform vision by pioneering novel, dropless platforms that can meaningfully advance the standard of care and improve outcomes for patients suffering from sight-threatening chronic eye diseases. Our mantra “We’ll Go First” embodies our commitment and determination to take chances and push the limits of science and technology to disrupt and improve the legacy treatment paradigms in glaucoma, corneal disorders, and retinal diseases.

 

At Johnson & Johnson Vision, we have a bold ambition: to change the trajectory of eye health. Through our operating companies, we’ve developed solutions for every stage of life-to help people see better, connect better, and live better. We partner with eye care professionals to provide some of the world's leading products and technologies to address refractive error, cataracts, dry eye, and beyond. We are committed to using our reach and size for good and strive to put quality eye care within reach of everyone, everywhere. Click the logo for more information. 

 

Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led for +36 years by physician-scientists, Regeneron's unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in Regeneron's laboratories. Regeneron's medicines and pipeline are designed to help patients, including patients with certain types of serious eye diseases.  

For more information, please visit www.regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook, or X. 


UCI School of Medicine

Office of Continuing Medical Education
5141 California Avenue, Suite 200B, Irvine, CA 92617
About Us & Accreditation Information

(949) 824-9163
[email protected]

See us on Facebook See us on Twitter See us on Instagram See us on Linked In See us on YouTube

Powered By CloudCME


© 2025 UC Regents. All Rights Reserved.
Copyright Inquiries | School of Medicine Accreditation Information | Privacy & Legal Notice